Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMZN Amazon.com	$270.64 -1.2%	$245.38	$196.00 ▼ $278.56	$2.91T	1.46	36.78 million shs	54.69 million shs
COIN Coinbase Global	$189.03 +3.7%	$188.59	$139.36 ▼ $444.64	$49.80B	3.38	9.18 million shs	10.23 million shs
CRSP CRISPR Therapeutics	$56.10 -0.5%	$51.36	$35.38 ▼ $78.48	$5.42B	1.74	1.63 million shs	1.93 million shs
GH Guardant Health	$129.69 -2.6%	$95.08	$38.03 ▼ $133.97	$17.20B	1.48	2.19 million shs	3.51 million shs
MRNA Moderna	$47.19 -0.8%	$50.24	$22.28 ▼ $59.55	$18.72B	1.05	7.61 million shs	6.31 million shs
PACB Pacific Biosciences of California	$1.49 +1.4%	$1.42	$0.96 ▼ $2.73	$462.80M	2.4	5.90 million shs	7.01 million shs
TSLA Tesla	$435.79 -1.4%	$391.84	$273.21 ▼ $498.83	$1.64T	1.79	50.32 million shs	45.04 million shs
TTD Trade Desk	$21.56 +1.9%	$22.25	$19.74 ▼ $91.45	$10.14B	1.1	19.11 million shs	48.41 million shs
U Unity Software	$30.40 +1.5%	$24.41	$16.78 ▼ $52.15	$13.30B	2.04	11.17 million shs	9.71 million shs

Don't wait for the SpaceX IPO

The space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMZN Amazon.com	0.00%	+1.62%	+2.11%	+28.88%	+32.20%
COIN Coinbase Global	0.00%	+2.18%	+0.67%	+7.50%	-25.66%
CRSP CRISPR Therapeutics	0.00%	+11.39%	+7.18%	-6.72%	+50.71%
GH Guardant Health	0.00%	+9.03%	+48.93%	+38.12%	+239.59%
MRNA Moderna	0.00%	+0.66%	+2.72%	-11.91%	+81.15%
PACB Pacific Biosciences of California	0.00%	+22.13%	-6.29%	-11.31%	+35.45%
TSLA Tesla	0.00%	+2.30%	+14.19%	+8.27%	+22.10%
TTD Trade Desk	0.00%	-3.66%	-8.61%	-9.49%	-71.98%
U Unity Software	0.00%	+19.25%	+15.03%	+67.65%	+23.64%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMZN Amazon.com	$270.64 -1.2%	$245.38	$196.00 ▼ $278.56	$2.91T	1.46	36.78 million shs	54.69 million shs
COIN Coinbase Global	$189.03 +3.7%	$188.59	$139.36 ▼ $444.64	$49.80B	3.38	9.18 million shs	10.23 million shs
CRSP CRISPR Therapeutics	$56.10 -0.5%	$51.36	$35.38 ▼ $78.48	$5.42B	1.74	1.63 million shs	1.93 million shs
GH Guardant Health	$129.69 -2.6%	$95.08	$38.03 ▼ $133.97	$17.20B	1.48	2.19 million shs	3.51 million shs
MRNA Moderna	$47.19 -0.8%	$50.24	$22.28 ▼ $59.55	$18.72B	1.05	7.61 million shs	6.31 million shs
PACB Pacific Biosciences of California	$1.49 +1.4%	$1.42	$0.96 ▼ $2.73	$462.80M	2.4	5.90 million shs	7.01 million shs
TSLA Tesla	$435.79 -1.4%	$391.84	$273.21 ▼ $498.83	$1.64T	1.79	50.32 million shs	45.04 million shs
TTD Trade Desk	$21.56 +1.9%	$22.25	$19.74 ▼ $91.45	$10.14B	1.1	19.11 million shs	48.41 million shs
U Unity Software	$30.40 +1.5%	$24.41	$16.78 ▼ $52.15	$13.30B	2.04	11.17 million shs	9.71 million shs

Don't wait for the SpaceX IPO

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMZN Amazon.com	0.00%	+1.62%	+2.11%	+28.88%	+32.20%
COIN Coinbase Global	0.00%	+2.18%	+0.67%	+7.50%	-25.66%
CRSP CRISPR Therapeutics	0.00%	+11.39%	+7.18%	-6.72%	+50.71%
GH Guardant Health	0.00%	+9.03%	+48.93%	+38.12%	+239.59%
MRNA Moderna	0.00%	+0.66%	+2.72%	-11.91%	+81.15%
PACB Pacific Biosciences of California	0.00%	+22.13%	-6.29%	-11.31%	+35.45%
TSLA Tesla	0.00%	+2.30%	+14.19%	+8.27%	+22.10%
TTD Trade Desk	0.00%	-3.66%	-8.61%	-9.49%	-71.98%
U Unity Software	0.00%	+19.25%	+15.03%	+67.65%	+23.64%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMZN Amazon.com	2.95	Moderate Buy	$312.83	15.59% Upside
COIN Coinbase Global	2.48	Hold	$252.10	33.37% Upside
CRSP CRISPR Therapeutics	2.53	Moderate Buy	$65.47	16.71% Upside
GH Guardant Health	2.86	Moderate Buy	$129.79	0.08% Upside
MRNA Moderna	1.84	Reduce	$35.73	-24.28% Downside
PACB Pacific Biosciences of California	1.80	Reduce	$1.83	23.04% Upside
TSLA Tesla	2.34	Hold	$395.20	-9.31% Downside
TTD Trade Desk	2.21	Hold	$33.91	57.29% Upside
U Unity Software	2.59	Moderate Buy	$38.77	27.51% Upside

Current Analyst Ratings Breakdown

Latest AMZN, PACB, GH, TTD, COIN, CRSP, TSLA, U, and MRNA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/29/2026	COIN Coinbase Global	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D+) ➝ Hold (C-)
5/29/2026	AMZN Amazon.com	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$310.00 ➝ $320.00
5/28/2026	GH Guardant Health	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy
5/28/2026	COIN Coinbase Global	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$226.00 ➝ $228.00
5/28/2026	TTD Trade Desk	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Sell	$11.00
5/27/2026	GH Guardant Health	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Buy	$155.00 ➝ $160.00
5/27/2026	AMZN Amazon.com	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
5/27/2026	CRSP CRISPR Therapeutics	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Market Outperform
5/26/2026	MRNA Moderna	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral
5/26/2026	GH Guardant Health	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$145.00 ➝ $155.00
5/21/2026	GH Guardant Health	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$127.00

(Data available from 5/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMZN Amazon.com	$716.92B	4.06	$13.36 per share	20.26	$41.08 per share	6.59
COIN Coinbase Global	$7.18B	6.93	$5.02 per share	37.66	$51.17 per share	3.69
CRSP CRISPR Therapeutics	$3.51M	1,541.44	N/A	N/A	$18.81 per share	2.98
GH Guardant Health	$982.02M	17.51	N/A	N/A	($1.37) per share	-94.66
MRNA Moderna	$1.94B	9.63	N/A	N/A	$18.67 per share	2.53
PACB Pacific Biosciences of California	$160.01M	2.89	$0.79 per share	1.89	$0.01 per share	149.00
TSLA Tesla	$94.83B	17.26	$2.66 per share	163.63	$22.56 per share	19.32
TTD Trade Desk	$2.90B	3.50	$1.17 per share	18.35	$5.22 per share	4.13
U Unity Software	$1.85B	7.18	$1.14 per share	26.77	$6.83 per share	4.45

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMZN Amazon.com	$77.67B	$8.36	32.37	27.01	2.03	12.22%	19.92%	9.86%	7/30/2026 (Estimated)
COIN Coinbase Global	$1.26B	$2.66	71.06	40.13	6.67	12.20%	4.16%	2.07%	7/30/2026 (Estimated)
CRSP CRISPR Therapeutics	-$581.60M	-$6.22	N/A	N/A	N/A	-13,856.54%	-25.66%	-20.39%	8/3/2026 (Estimated)
GH Guardant Health	-$416.28M	-$3.39	N/A	N/A	N/A	-40.10%	N/A	-26.42%	7/29/2026 (Estimated)
MRNA Moderna	-$2.82B	-$8.15	N/A	N/A	N/A	-143.55%	-26.64%	-19.32%	7/31/2026 (Estimated)
PACB Pacific Biosciences of California	-$546.38M	-$0.43	N/A	N/A	N/A	-80.35%	-571.06%	-18.82%	8/3/2026 (Estimated)
TSLA Tesla	$3.79B	$1.09	399.81	254.85	17.21	3.95%	4.89%	2.93%	7/22/2026 (Estimated)
TTD Trade Desk	$443.30M	$0.88	24.50	15.74	1.04	14.57%	16.91%	7.28%	8/6/2026 (Estimated)
U Unity Software	-$402.77M	-$1.57	N/A	55.28	3.90	-34.99%	-1.30%	-0.61%	8/5/2026 (Estimated)

Latest AMZN, PACB, GH, TTD, COIN, CRSP, TSLA, U, and MRNA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/7/2026	Q1 2026	COIN Coinbase Global	$0.0638	-$1.49	-$1.5538	-$1.49	$1.49 billion	$1.41 billion
5/7/2026	Q1 2026	PACB Pacific Biosciences of California	-$0.17	-$0.12	+$0.05	-$0.03	$39.94 million	$37.18 million
5/7/2026	Q1 2026	TTD Trade Desk	$0.32	$0.08	-$0.24	$0.08	$678.87 million	$688.86 million
5/4/2026	Q1 2026	CRSP CRISPR Therapeutics	-$1.2185	-$1.28	-$0.0615	-$1.28	$6.06 million	$1.46 million
5/1/2026	Q1 2026	MRNA Moderna	-$3.02	-$3.40	-$0.38	-$3.40	$236.37 million	$389.00 million
4/29/2026	Q1 2026	AMZN Amazon.com	$1.63	$2.78	+$1.15	$2.78	$177.28 billion	$181.52 billion
4/23/2026	Q1 2026	TSLA Tesla	$0.39	$0.41	+$0.02	$0.13	$22.96 billion	$22.39 billion
3/31/2026	Q1 2026	CRSP CRISPR Therapeutics	N/A	-$1.28	N/A	-$1.28	N/A	$1.46 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMZN Amazon.com	N/A	N/A	N/A	N/A	N/A
COIN Coinbase Global	N/A	N/A	N/A	N/A	N/A
CRSP CRISPR Therapeutics	N/A	N/A	N/A	N/A	N/A
GH Guardant Health	N/A	N/A	N/A	N/A	N/A
MRNA Moderna	N/A	N/A	N/A	N/A	N/A
PACB Pacific Biosciences of California	N/A	N/A	N/A	N/A	N/A
TSLA Tesla	N/A	N/A	N/A	N/A	N/A
TTD Trade Desk	N/A	N/A	N/A	N/A	N/A
U Unity Software	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMZN Amazon.com	0.27	1.18	1.01
COIN Coinbase Global	0.44	2.14	2.34
CRSP CRISPR Therapeutics	0.32	17.97	17.96
GH Guardant Health	N/A	4.68	4.39
MRNA Moderna	0.08	2.41	2.35
PACB Pacific Biosciences of California	N/A	5.65	4.87
TSLA Tesla	0.09	2.04	1.62
TTD Trade Desk	N/A	1.68	1.68
U Unity Software	0.56	1.95	1.95

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMZN Amazon.com	72.20%
COIN Coinbase Global	68.84%
CRSP CRISPR Therapeutics	69.20%
GH Guardant Health	92.60%
MRNA Moderna	75.33%
PACB Pacific Biosciences of California	N/A
TSLA Tesla	66.20%
TTD Trade Desk	67.77%
U Unity Software	73.46%

Insider Ownership

Company	Insider Ownership
AMZN Amazon.com	8.90%
COIN Coinbase Global	16.66%
CRSP CRISPR Therapeutics	4.30%
GH Guardant Health	5.60%
MRNA Moderna	10.80%
PACB Pacific Biosciences of California	2.50%
TSLA Tesla	19.90%
TTD Trade Desk	11.41%
U Unity Software	0.77%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMZN Amazon.com	1,576,000	10.76 billion	9.80 billion	Optionable
COIN Coinbase Global	4,951	263.46 million	219.57 million	Optionable
CRSP CRISPR Therapeutics	460	96.45 million	92.30 million	Optionable
GH Guardant Health	2,506	132.60 million	125.17 million	Not Optionable
MRNA Moderna	4,700	396.79 million	353.93 million	Optionable
PACB Pacific Biosciences of California	730	310.60 million	302.84 million	Optionable
TSLA Tesla	134,785	3.76 billion	3.01 billion	Optionable
TTD Trade Desk	3,843	470.11 million	416.47 million	Optionable
U Unity Software	4,412	436.54 million	433.17 million	Not Optionable

AMZN, PACB, GH, TTD, COIN, CRSP, TSLA, U, and MRNA Headlines

Recent News About These Companies

Matthew Bromberg Sells 138,993 Shares of Unity Software (NYSE:U) Stock

May 30 at 4:43 AM | americanbankingnews.com

AppLovin's Revenue Momentum Reflects AI-Driven Advertising Demand

May 29 at 3:06 PM | finance.yahoo.com

Why Unity Software Inc. (U) is a Top Momentum Stock for the Long-Term

May 29 at 10:50 AM | zacks.com

What Makes Unity (U) an Investment Choice?

May 29 at 9:52 AM | finance.yahoo.com

What Makes Unity (U) an Investment Choice?

May 29 at 9:51 AM | insidermonkey.com

Insider Selling: Unity Software (NYSE:U) SVP Sells 952 Shares of Stock

May 29 at 8:47 AM | insidertrades.com

Rebecca Berenice Boyden Sells 952 Shares of Unity Software (NYSE:U) Stock

May 28 at 9:19 PM | marketbeat.com

Alexander Blum Sells 2,099 Shares of Unity Software (NYSE:U) Stock

May 28 at 9:19 PM | marketbeat.com

Alexander Blum Sells 19,009 Shares of Unity Software (NYSE:U) Stock

May 28 at 9:19 PM | marketbeat.com

Jarrod Yahes Sells 24,021 Shares of Unity Software (NYSE:U) Stock

May 28 at 9:19 PM | marketbeat.com

Unity Software (NYSE:U) CEO Sells $3,777,829.74 in Stock

May 28 at 9:18 PM | marketbeat.com

Unity AI Expansion Keeps Software Markets Watching Closely

May 28 at 6:21 PM | kalkinemedia.comK

Earnings Estimates Moving Higher for Unity Software (U): Time to Buy?

May 28 at 6:21 PM | finance.yahoo.com

Earnings Estimates Moving Higher for Unity Software (U): Time to Buy?

May 28 at 1:21 PM | zacks.com

Wall Street Analysts Think Unity Software (U) Could Surge 37.62%: Read This Before Placing a Bet

May 27, 2026 | finance.yahoo.com

Video Game Giant Could Resume Pullback Says Bear Signal

May 27, 2026 | schaeffersresearch.com

Wall Street Analysts Think Unity Software (U) Could Surge 37.62%: Read This Before Placing a Bet

May 27, 2026 | zacks.com

Unity Gains on Vector Momentum: How to Play the Stock in 2H26?

May 25, 2026 | finance.yahoo.com

Should You Buy, Sell or Hold Unity Stock Now for 2H26 Gains?

May 25, 2026 | finance.yahoo.com

Unity Rides on AI Integration and Ad Tech Push: What's Ahead?

May 25, 2026 | finance.yahoo.com

Should You Buy, Sell or Hold Unity Stock Now for 2H26 Gains?

May 25, 2026 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

AMZN, PACB, GH, TTD, COIN, CRSP, TSLA, U, and MRNA Company Descriptions

Amazon.com NASDAQ:AMZN

$270.64 -3.36 (-1.23%)

Closing price 05/29/2026 04:00 PM Eastern

Extended Trading

$270.52 -0.12 (-0.04%)

As of 05/29/2026 07:59 PM Eastern

Amazon.com, Inc. engages in the retail sale of consumer products, advertising, and subscriptions service through online and physical stores in North America and internationally. The company operates through three segments: North America, International, and Amazon Web Services (AWS). It also manufactures and sells electronic devices, including Kindle, Fire tablets, Fire TVs, Echo, Ring, Blink, and eero; and develops and produces media content. In addition, the company offers programs that enable sellers to sell their products in its stores; and programs that allow authors, independent publishers, musicians, filmmakers, Twitch streamers, skill and app developers, and others to publish and sell content. Further, it provides compute, storage, database, analytics, machine learning, and other services, as well as advertising services through programs, such as sponsored ads, display, and video advertising. Additionally, the company offers Amazon Prime, a membership program. The company's products offered through its stores include merchandise and content purchased for resale and products offered by third-party sellers. It serves consumers, sellers, developers, enterprises, content creators, advertisers, and employees. Amazon.com, Inc. was incorporated in 1994 and is headquartered in Seattle, Washington.

Coinbase Global NASDAQ:COIN

$189.03 +6.78 (+3.72%)

Closing price 05/29/2026 04:00 PM Eastern

Extended Trading

$188.52 -0.51 (-0.27%)

As of 05/29/2026 08:00 PM Eastern

Coinbase Global, Inc. provides financial infrastructure and technology for the crypto economy in the United States and internationally. The company offers the primary financial account in the crypto economy for consumers; and a marketplace with a pool of liquidity for transacting in crypto assets for institutions. It also provides technology and services that enable developers to build crypto products and securely accept crypto assets as payment. The company was founded in 2012 and is based in Wilmington, Delaware.

CRISPR Therapeutics NASDAQ:CRSP

$56.10 -0.28 (-0.50%)

Closing price 05/29/2026 03:59 PM Eastern

Extended Trading

$55.65 -0.45 (-0.80%)

As of 05/29/2026 07:58 PM Eastern

CRISPR Therapeutics is a gene-editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene-editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom. For more information, please visit www.crisprtx.com.

Guardant Health NASDAQ:GH

$129.69 -3.53 (-2.65%)

Closing price 05/29/2026 04:00 PM Eastern

Extended Trading

$129.08 -0.61 (-0.47%)

As of 05/29/2026 07:58 PM Eastern

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Moderna NASDAQ:MRNA

$47.19 -0.38 (-0.80%)

Closing price 05/29/2026 04:00 PM Eastern

Extended Trading

$47.36 +0.17 (+0.35%)

As of 05/29/2026 08:00 PM Eastern

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Pacific Biosciences of California NASDAQ:PACB

$1.49 +0.02 (+1.36%)

Closing price 05/29/2026 04:00 PM Eastern

Extended Trading

$1.48 -0.01 (-0.87%)

As of 05/29/2026 07:55 PM Eastern

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

Tesla NASDAQ:TSLA

$435.79 -6.31 (-1.43%)

Closing price 05/29/2026 04:00 PM Eastern

Extended Trading

$434.37 -1.42 (-0.33%)

As of 05/29/2026 07:59 PM Eastern

Tesla, Inc. designs, develops, manufactures, leases, and sells electric vehicles, and energy generation and storage systems in the United States, China, and internationally. The company operates in two segments, Automotive, and Energy Generation and Storage. The Automotive segment offers electric vehicles, as well as sells automotive regulatory credits; and non-warranty after-sales vehicle, used vehicles, body shop and parts, supercharging, retail merchandise, and vehicle insurance services. This segment also provides sedans and sport utility vehicles through direct and used vehicle sales, a network of Tesla Superchargers, and in-app upgrades; purchase financing and leasing services; services for electric vehicles through its company-owned service locations and Tesla mobile service technicians; and vehicle limited warranties and extended service plans. The Energy Generation and Storage segment engages in the design, manufacture, installation, sale, and leasing of solar energy generation and energy storage products, and related services to residential, commercial, and industrial customers and utilities through its website, stores, and galleries, as well as through a network of channel partners; and provision of service and repairs to its energy product customers, including under warranty, as well as various financing options to its solar customers. The company was formerly known as Tesla Motors, Inc. and changed its name to Tesla, Inc. in February 2017. Tesla, Inc. was incorporated in 2003 and is headquartered in Austin, Texas.

Trade Desk NASDAQ:TTD

$21.56 +0.41 (+1.94%)

Closing price 05/29/2026 04:00 PM Eastern

Extended Trading

$21.58 +0.02 (+0.09%)

As of 05/29/2026 07:59 PM Eastern

The Trade Desk, Inc. operates as a technology company in the United States and internationally. The company offers a self-service cloud-based platform that allows buyers to plan, manage, optimize, and measure data-driven digital advertising campaigns across various ad formats and channels, including video, display, audio, digital-out-of-home, native, and social on various devices, such as computers, mobile devices, televisions, and streaming devices. It provides data and other value-added services. The company serves advertising agencies, brands, and other service providers for advertisers. The Trade Desk, Inc. was incorporated in 2009 and is headquartered in Ventura, California.

Unity Software NYSE:U

$30.40 +0.46 (+1.55%)

Closing price 05/29/2026 03:59 PM Eastern

Extended Trading

$30.51 +0.11 (+0.35%)

As of 05/29/2026 07:59 PM Eastern

Unity Software Inc. operates a real-time 3D development platform. Its platform provides software solutions to create, run, and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The company offers its solutions directly through its online store and field sales operations in North America, Denmark, Finland, the United Kingdom, Germany, Japan, China, Singapore, and South Korea, as well as indirectly through independent distributors and resellers worldwide. The company was founded in 2004 and is headquartered in San Francisco, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AMZN, PACB, GH, TTD, COIN, CRSP, TSLA, U, and MRNA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AMZN, PACB, GH, TTD, COIN, CRSP, TSLA, U, and MRNA Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AMZN, PACB, GH, TTD, COIN, CRSP, TSLA, U, and MRNA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

AMZN, PACB, GH, TTD, COIN, CRSP, TSLA, U, and MRNA Company Descriptions

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools